USP45 Antibodies

Santa Cruz Biotechnology features a diverse variety of USP45 monoclonal antibodies for advanced research in cellular biology. USP45 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). USP45, or Ubiquitin Specific Peptidase 45, plays a critical role in the regulation of protein degradation and cellular signaling pathways by removing ubiquitin moieties from target proteins. This function is essential for maintaining cellular homeostasis and influencing processes such as cell cycle progression and apoptosis. The study of USP45 has revealed significant insights into various diseases, including cancer, where dysregulation of ubiquitin-mediated proteolysis can lead to tumorigenesis. Understanding USP45's role in cellular processes helps researchers develop targeted therapeutic strategies for treating various pathological conditions. Investigating USP45's functions can provide valuable information about protein degradation pathways and their impact on cellular health. Research using USP45 monoclonal antibodies from Santa Cruz Biotechnology enables scientists to advance our understanding of cellular regulation and contribute to meaningful discoveries in biomedical research.